Shouping Xu | Biology and Life Sciences | Best Researcher Award

Assoc. Prof. Dr. Shouping Xu | Biology and Life Sciences | Best Researcher Award

Assoc. Prof. Dr. Shouping Xu | Biology and Life Sciences | Medical Physicist | Cancer Hospital Chinese Academy of Medical Sciences | China

Assoc. Prof. Dr. Shouping Xu is a distinguished medical physicist specializing in radiation oncology, with extensive expertise in advanced radiotherapy techniques and the integration of artificial intelligence in cancer treatment. He holds degrees in nuclear physics and medical physics from leading Chinese institutions and has served in senior leadership roles as Chief Clinical Medical Physicist at the Cancer Hospital, Chinese Academy of Medical Sciences, and previously at the Chinese PLA General Hospital and Yi Zhou Proton Therapy Center. Assoc. Prof. Dr. Shouping Xu  has made significant contributions to the development of innovative dose prediction models, proton therapy planning, and image-guided radiotherapy, with numerous publications in high-impact international journals. His active engagement in global conferences, memberships in professional societies, and certifications from recognized boards reflect his commitment to advancing medical physics. Widely respected for both his clinical leadership and research excellence, Assoc. Prof. Dr. Shouping Xu continues to play a key role in shaping the future of precision radiotherapy and medical imaging technologies.

Professional Profile 

Education  

Assoc. Prof. Dr. Shouping Xu has a strong academic background in physics and medical physics, beginning with a Bachelor of Science degree in Nuclear Physics Technology from Lanzhou University, China. He went on to pursue advanced studies at Tsinghua University, where he earned a Master of Science degree in Medical Physics from the Department of Engineering Physics, followed by a Doctor of Philosophy in Medical Physics from the same department. His education provided a solid foundation in radiation physics, imaging, and advanced treatment technologies, which has been central to his career in radiation oncology and his contributions to clinical innovation and research in medical physics.

Professional Experience

Assoc. Prof. Dr. Shouping Xu has built an extensive professional career in medical physics, holding key clinical and leadership positions in some of China’s most renowned cancer treatment centers. He currently serves as Chief Clinical Medical Physicist at the Proton Center of the Cancer Hospital, Chinese Academy of Medical Sciences, where he oversees clinical operations, quality management, and research in advanced radiotherapy. Previously, he was Chief Medical Physicist and Vice Director at the Yi Zhou Proton Therapy Center, where he played a pivotal role in establishing clinical workflows and implementing cutting-edge proton and photon therapies. Earlier in his career, he served at the Chinese PLA General Hospital as Chief and Senior Medical Physicist, contributing to innovations in IMRT, image-guided radiotherapy, and quality assurance. With responsibilities ranging from managing multidisciplinary teams to developing clinical protocols and engaging in pioneering research, Assoc. Prof. Dr. Shouping Xu has consistently demonstrated leadership, technical expertise, and a strong commitment to advancing radiation oncology practices.

Research Interest

Assoc. Prof. Dr. Shouping Xu’s research interests lie at the intersection of medical physics, radiation oncology, and artificial intelligence, with a focus on advancing precision radiotherapy. His work emphasizes the development of AI-driven algorithms and deep learning models for dose prediction, treatment planning, and image-guided radiotherapy, aiming to improve both the efficiency and accuracy of cancer treatment. He has conducted extensive studies on proton therapy, CyberKnife radiosurgery, and advanced techniques such as VMAT, IMRT, and adaptive radiotherapy, contributing to innovations in treatment optimization and quality assurance. Additionally, his research explores deformable image registration, dose verification, and the clinical application of AI for enhancing radiotherapy workflows. By bridging physics, engineering, and oncology, Assoc. Prof. Dr. Shouping Xu is committed to translating cutting-edge technologies into practical clinical tools that improve outcomes and safety for cancer patients.

Award and Honor

Assoc. Prof. Dr. Shouping Xu has earned recognition for his significant contributions to medical physics and radiation oncology through his active involvement in international conferences, professional societies, and research achievements. He has been an invited speaker and presenter at prestigious forums such as the AAPM Annual Meetings, the IUPESM World Congress on Medical Physics and Biomedical Engineering, and the Asia-Oceania Congress of Medical Physics, where his work on advanced radiotherapy techniques and AI-driven innovations has been highlighted. His leadership roles as Chief Clinical Medical Physicist and his certifications from the Chinese Board of Medical Physicists (CBMP) and the Chinese Board of Radiation Protection (CBRP) further underscore his professional excellence. Through his research, publications, and professional service, Assoc. Prof. Dr. Shouping Xu has gained both national and international recognition, reflecting his status as a highly respected figure in the field of medical physics.

Publications Top Noted

Dosimetric evaluation of intensity modulated proton therapy and photon volumetric modulated arc therapy for bilateral breast cancer
Year: 2025

Virtual-simulation boosted neural network dose calculation engine for intensity-modulated radiation therapy
Year: 2025

Dose rate correction of a diode array for universal wedge field dosimetric verification
Year: 2025

gMCAP: a GPU-based Monte Carlo proton transport program for high-density tissues with precise nuclear reaction models
Year: 2025

An AI dose-influence matrix engine for robust pencil beam scanning protons therapy
Year: 2025

A feasibility study of dose-band prediction in radiation therapy: Predicting a spectrum of plan dose
Year: 2025

A StarGAN and transformer-based hybrid classification-regression model for multi-institution VMAT patient-specific quality assurance
Year: 2025

Dose prediction of CyberKnife Monte Carlo plan for lung cancer patients based on deep learning: robust learning of variable beam configurations
Year: 2024

Dosimetric comparison of ZAP-X, Gamma Knife, and CyberKnife stereotactic radiosurgery for single brain metastasis
Year: 2024

Conclusion

Assoc. Prof. Dr. Shouping Xu is highly suitable for the Best Researcher Award. His combination of clinical leadership, innovative research in AI-driven radiation therapy, and active participation in international scientific forums positions him as a thought leader in medical physics and oncology. With his strong portfolio of publications and pioneering approaches to radiation therapy planning and quality assurance, he demonstrates both scientific excellence and clinical relevance. With further emphasis on international collaborations and translational outcomes, his contributions will continue to shape the future of precision radiotherapy.

Ian Dubery | Biology and Life Sciences | Excellence in Research Award

Ian Dubery | Biology and Life Sciences | Excellence in Research Award

Prof Ian Dubery, University of Johannesburg, South Africa

Prof. Ian Dubery is a distinguished biochemist specializing in plant biochemistry, molecular biology, and agricultural biotechnology 🌱🔬. With a Ph.D. (cum laude) from Rand Afrikaans University, he has held esteemed roles, including Research Professor and Director of the Research Centre for Plant Metabolomics 🌾. His research focuses on plant-pathogen interactions, defense mechanisms, and metabolomics, boasting over 216 journal publications 📚✨. An NRF-rated scientist with an h-index of 52 (Google Scholar), he has supervised 50+ M.Sc. and 23 Ph.D. students 🎓. His accolades include the Boehringer Mannheim Prize and Alexander von Humboldt Foundation fellowships 🏆🌍.

Publication Profile

Orcid

Academic Background

Prof. Ian Dubery 🎓 earned all his academic qualifications in biochemistry with distinction (cum laude) from Rand Afrikaans University (RAU), Johannesburg, South Africa. He completed his B.Sc. in Biochemistry and Chemistry in 1975 🧪, followed by a B.Sc. Hons. in Biochemistry in 1976 📜. He achieved his M.Sc. in Biochemistry in 1981 🥼 and culminated his academic journey with a Ph.D. in Biochemistry in 1986 🧬. Prof. Dubery’s outstanding academic performance reflects his dedication and expertise in the field of biochemistry, laying the foundation for his illustrious career as a researcher and educator. 🌟

Awards and Recognition

Professor Ian Dubery, a distinguished scientist, has received numerous accolades throughout his career 🌟. He was the highest academic achiever in Biochemistry and Chemistry (1975) 🧪 and earned B.Sc. (1975) and B.Sc. Hons. (1976) degrees with top honors 🎓. His awards include the Boehringer Mannheim Prize 🏅, Alexander von Humboldt Fellowships 🇩🇪, and the SA Biochemical Society Gold Medal (2016) 🥇. A globally recognized researcher with an h-index of 52 📊, he has been an NRF-rated scientist since 1998 🔬. Recent achievements include the Hertzog Prize for Science & Technology (2024) and NSTF finalist recognition in 2020 🌍.

Experience

Prof. Ian Dubery has been a distinguished educator and researcher in biochemistry and molecular biology since 1982, teaching at the University of Johannesburg. 📚👨‍🏫 He has supervised 50 M.Sc. and 23 Ph.D. students, fostering academic growth. 🌟 As a scientist, he has contributed extensively, publishing 216+ articles in international journals. 📝🔬 His research collaborations span prestigious institutions, including the Max Planck Institute and Salk Institute. 🌍💡 With leadership roles as Chair of Biochemistry and committee memberships in ethics and research, he has excelled in academic management and scientific innovation. 🏢📈 Prof. Dubery remains a prominent figure in biochemical research. 🧬✨

Mentorship and Impact

Prof. Ian Dubery is a dedicated academic and mentor, shaping the next generation of scientists with excellence. 🌟 Over his illustrious career, he has supervised 50 M.Sc. and 23 Ph.D. students, guiding them toward impactful research and scientific achievements. 📚🔬 His mentorship emphasizes critical thinking, innovation, and scientific rigor, empowering students to excel in their respective fields. 🌱✨ With a passion for fostering academic growth and nurturing young talent, Prof. Dubery continues to inspire the scientific community. 🧪🎓 His legacy as an educator and mentor reflects his unwavering commitment to advancing knowledge and building future leaders in science. 🌍👏

Innovative Focus

Prof. Ian Dubery is a distinguished scholar in metabolomics, plant protection, and biochemistry, whose groundbreaking work addresses contemporary agricultural and environmental challenges. 🌱🔬 His research explores the intricate biochemical mechanisms in plants, advancing our understanding of their defense systems and resilience. 🌿🛡️ Prof. Dubery’s contributions have significant implications for sustainable agriculture and environmental conservation, providing innovative solutions to global challenges. 🌍💡 With numerous publications and impactful research, he remains a leading figure in the scientific community, inspiring advancements in plant sciences and beyond. 📚✨ His dedication to knowledge and innovation is shaping the future of agricultural sustainability. 🚜🌾

Research Focus

Prof. Ian A. Dubery’s research focuses on plant metabolomics, particularly in response to biotic stresses and defense mechanisms. His work integrates targeted metabolome and transcript profiling to understand plant chemical responses to pathogens like Pseudomonas syringae and Puccinia striiformis. He explores metabolite profiling of crops such as oats, sorghum, wheat, and barley, investigating the biochemical pathways triggered by infections and plant interactions with microorganisms. His studies contribute to improving plant resistance, understanding biosynthesis, and advancing crop protection strategies through the use of chemical and molecular profiling techniques. 🌱🔬🌾🧬

Publication Top Notes